Obsidian Vitality (NYSE:OBE) late on Monday revised its capital expenditure outlook downwards by roughly $15 million, reallocating a portion of sunshine oil spending in the direction of incremental share buybacks, citing market uncertainty.
The corporate has, in the meantime, elevated its 2024 manufacturing steering vary to 37,000 to 37,400